DEPRESSION AND CARDIAC DISEASES (REVIEW OF LITERATURE)

The article deals with the important problem in the field of consultative psychiatry - comorbid depressive disorders in patients with cardiovascular diseases. Depression is highly prevalent in cardiac patients. Between 31-45 % of patients with coronary artery disease suffer from clinically significa...

Descripción completa

Guardado en:

Detalles Bibliográficos
Autores principales:	E. V. Vinokurov, V. S. Sobennikov
Formato:	article
Lenguaje:	RU
Publicado:	Scientific Сentre for Family Health and Human Reproduction Problems 2017
Materias:	depression cardiac disease adverse cardiac outcomes Science Q
Acceso en línea:	https://doaj.org/article/c3b80650040c48d9857dba93ad4df4fd
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!

id	oai:doaj.org-article:c3b80650040c48d9857dba93ad4df4fd
record_format	dspace
spelling	oai:doaj.org-article:c3b80650040c48d9857dba93ad4df4fd2021-11-23T06:14:38ZDEPRESSION AND CARDIAC DISEASES (REVIEW OF LITERATURE)2541-94202587-959610.12737/article_59fad516bdb3e0.52521063https://doaj.org/article/c3b80650040c48d9857dba93ad4df4fd2017-07-01T00:00:00Zhttps://www.actabiomedica.ru/jour/article/view/414https://doaj.org/toc/2541-9420https://doaj.org/toc/2587-9596The article deals with the important problem in the field of consultative psychiatry - comorbid depressive disorders in patients with cardiovascular diseases. Depression is highly prevalent in cardiac patients. Between 31-45 % of patients with coronary artery disease suffer from clinically significant depressive symptoms. Furthermore, 20 % of patients with coronary heart disease meet criteria for the major depressive disorder. Patients with heartfailure, atrial fibrillation and ones undergoing implantable cardioverter-defibrillator placement are similarly at increased risk for elevated depressive symptoms and for major depressive disorder. In patients with heart diseases, depression is chronic, persistent, and associated with worse health-related quality of life, recurrent cardiac events, and mortality. At present, pharmacologic and psychotherapeutic interventions appear to be safe and effective at reducing depressive symptoms in patients with cardiovascular diseases and may impact cardiac outcomes. Despite this, depression remains under-recognized and undertreated in patients at risk for or living with cardiovascular diseases. In this review, we summarize the evidence linking depression to increased risk of cardiovascular diseases and worse patient outcomes. The paper presents a review of the literature on epidemiology, comorbid conditions, and risk factors for depression in heart diseases. Future studies in this direction with involvement of cardiologists and psychiatrists should be held.E. V. VinokurovV. S. SobennikovScientific Сentre for Family Health and Human Reproduction Problemsarticledepressioncardiac diseaseadverse cardiac outcomesScienceQRUActa Biomedica Scientifica, Vol 2, Iss 4, Pp 63-67 (2017)
institution	DOAJ
collection	DOAJ
language	RU
topic	depression cardiac disease adverse cardiac outcomes Science Q
spellingShingle	depression cardiac disease adverse cardiac outcomes Science Q E. V. Vinokurov V. S. Sobennikov DEPRESSION AND CARDIAC DISEASES (REVIEW OF LITERATURE)
description	The article deals with the important problem in the field of consultative psychiatry - comorbid depressive disorders in patients with cardiovascular diseases. Depression is highly prevalent in cardiac patients. Between 31-45 % of patients with coronary artery disease suffer from clinically significant depressive symptoms. Furthermore, 20 % of patients with coronary heart disease meet criteria for the major depressive disorder. Patients with heartfailure, atrial fibrillation and ones undergoing implantable cardioverter-defibrillator placement are similarly at increased risk for elevated depressive symptoms and for major depressive disorder. In patients with heart diseases, depression is chronic, persistent, and associated with worse health-related quality of life, recurrent cardiac events, and mortality. At present, pharmacologic and psychotherapeutic interventions appear to be safe and effective at reducing depressive symptoms in patients with cardiovascular diseases and may impact cardiac outcomes. Despite this, depression remains under-recognized and undertreated in patients at risk for or living with cardiovascular diseases. In this review, we summarize the evidence linking depression to increased risk of cardiovascular diseases and worse patient outcomes. The paper presents a review of the literature on epidemiology, comorbid conditions, and risk factors for depression in heart diseases. Future studies in this direction with involvement of cardiologists and psychiatrists should be held.
format	article
author	E. V. Vinokurov V. S. Sobennikov
author_facet	E. V. Vinokurov V. S. Sobennikov
author_sort	E. V. Vinokurov
title	DEPRESSION AND CARDIAC DISEASES (REVIEW OF LITERATURE)
title_short	DEPRESSION AND CARDIAC DISEASES (REVIEW OF LITERATURE)
title_full	DEPRESSION AND CARDIAC DISEASES (REVIEW OF LITERATURE)
title_fullStr	DEPRESSION AND CARDIAC DISEASES (REVIEW OF LITERATURE)
title_full_unstemmed	DEPRESSION AND CARDIAC DISEASES (REVIEW OF LITERATURE)
title_sort	depression and cardiac diseases (review of literature)
publisher	Scientific Сentre for Family Health and Human Reproduction Problems
publishDate	2017
url	https://doaj.org/article/c3b80650040c48d9857dba93ad4df4fd
work_keys_str_mv	AT evvinokurov depressionandcardiacdiseasesreviewofliterature AT vssobennikov depressionandcardiacdiseasesreviewofliterature
_version_	1718417031866351616

DEPRESSION AND CARDIAC DISEASES (REVIEW OF LITERATURE)

Ejemplares similares